Patrys Ltd (ASX: PAB) Share Price and News

Dr. Campbell has over 30 years of international biotechnology research, management and leadership experience and has been involved in the creation and/or transformation of Australian and international biotechnology companies. Dr. Campbell was previously the CFO and COO of ChemGenex Pharmaceuticals Limited (ASX: CXS), where, as a member of the executive team he helped transform a research based company with a market capitalization of $10M to a company with completed clinical trials and regulatory dossiers submitted to the FDA and EMA. In 2011 ChemGenex was sold to Cephalon for $230M. Dr. Campbell was a foundation executive of Evolve Biosystems, and has assisted private biotechnology companies in Australia, New Zealand and the USA with capital raising and partnering negotiations. Dr Campbell chairs the board of Australia's peak industry body for biotechnology, AusBiotech.

Mr Christie has served on the boards of several public companies in the resource sector since 2006 and has developed interests in hospitality and property development.
Mr. Christie is the Director of Hawkins Christie Management Services, a firm based in Nedlands,
Western Australia, providing accounting and management services. He is also the current President of the South Fremantle Football Club, a role he has held since 2018, following over a decade of service on the club's board. His leadership has been instrumental in the club's strategic growth and community engagement initiatives.

Dr. Anton Uvarov has experience in the healthcare sector, with a particular focus on
neuroscience. He began his career in biotechnology investment as an equities analyst at Citigroup and
has since co-founded and served as a director of several ASX-listed companies, including clinical-stage
ventures such as Dimerix (ASX:DXB) and Actinogen Medical (ASX:ACW).
Dr. Uvarov is currently a Non-Executive Director of Neuroscientific Biopharmaceuticals (ASX:NSB), and
previously served on the board of Imugene (ASX:IMU), a late-stage clinical oncology company. Dr.
Uvarov is also the Executive Director and co-founder of BlinkLab (ASX:BB1), a digital diagnostics
company focused on autism.

Mr Ross has over 10 years of experience in accounting and secretarial services for ASX listed companies. His experience includes ASX compliance, corporate governance control and implementation, statutory financial reporting, shareholder meeting requirements, capital raising management, and board and secretarial support.

-

-